C. Carvallo

Improved survival in steroid‐refractory acute graft versus host disease after non‐myeloablative allogeneic transplantation using a daclizumab‐based strategy with comprehensive infection prophylaxis

N. Geller, R. Srinivasan, A. Barrett, 2004, British journal of haematology.

Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors

R. Childs, C. Carvallo, 2003, Cytotechnology.

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.

J. P. McCoy, R. Srinivasan, N. Young, 2004, Blood.

Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.

R. Childs, C. Dunbar, E. Sloand, 2002, Experimental hematology.

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors.

N. Geller, W. Linehan, R. Srinivasan, 2004, Blood.

Allogeneic Hematopoietic Blood-Cell Transplantation As Immunotherapy for Metastatic Renal Cell Carcinoma

R. Childs, C. Carvallo, 2004 .